Lucid Diagnostics Inc. (LUCD) Financials

LUCD Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 34.1 million 30.1 million
Dec. 31, 2025 40.4 million 29.5 million
Sept. 30, 2025 53.2 million 27.4 million
June 30, 2025 38.7 million 30.8 million

LUCD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -12.3 million 1.4 billion
Dec. 31, 2025 -12.6 million 2.3 billion
Sept. 30, 2025 -10.9 million 1.2 million
June 30, 2025 -10.6 million 1.1 million

LUCD Net Income

No data available :(

LUCD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 27.9 million - 695000
Dec. 31, 2025 34.7 billion - 927000
Sept. 30, 2025 47.3 million - 1.2 million
June 30, 2025 31.1 million - 2.3 million

LUCD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 101.9 million
Dec. 31, 2025 101.9 million
Sept. 30, 2025 108.2 million
June 30, 2025 99.0 million

LUCD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 215000 1.2 million 10.4 billion 5.0 billion
Dec. 31, 2025 51000 1.7 million 11.8 million 5.3 million
Sept. 30, 2025 28000 1.3 million 9.9 million 4.3 million
June 30, 2025 25000 1.3 million 9.6 billion 4.0 billion

LUCD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 million 1.8 million
Dec. 31, 2025 1.5 million 1.9 million
Sept. 30, 2025 1.2 million 1.7 million
June 30, 2025 1.2 million 1.8 million

LUCD

Price: $0.98

52 week price:
0.90
1.63

Earnings Per Share: -0.34 USD

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 72027

Market Capitalization: 105.4 million

Links: